Targets and mechanisms of chemically induced aneuploidy. Part 1 of the report of the 2017 IWGT workgroup on assessing the risk of aneugens for carcinogenesis and hereditary diseases
Anthony M. Lynch, David Tweats(Swansea University), Francesca Pacchierotti(National Agency for New Technologies, Energy and Sustainable Economic Development), Francesco Marchetti(Health Canada), David A. Eastmond, Maik Schuler(Pfizer (United States)), Micheline Kirsch‐Volders(Vrije Universiteit Brussel), Azeddine Elhajouji(Novartis (Switzerland)), Roland Froetschl(Federal Institute for Drugs and Medical Devices), Kenichi Masumura(National Institute of Health Sciences)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
March 2, 2019
Cited by 41
Related Papers
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2007|437
The in vivo Pig-a assay: A report of the International Workshop On Genotoxicity Testing (IWGT) Workgroup
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2014|156
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2006|131
Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells
|Mutation Research Letters|1995|119
Improvement of in vivo genotoxicity assessment: Combination of acute tests and integration into standard toxicity testing
|Mutation Research/Genetic Toxicology and Environmental Mutagenesis|2010|106